Literature DB >> 19373678

PRPF31 alternative splicing and expression in human retina.

Goranka Tanackovic1, Carlo Rivolta.   

Abstract

PURPOSE: To provide a mechanistic link between mutations in PRPF31, and essential and ubiquitously expressed gene, and retinitis pigmentosa, a disorder restricted to the eye.
METHODS: We investigated the existence of retina-specific PRPF31 isoforms and the expression of this gene in human retina and other tissues, as well as in cultured human cell lines. PRPF31 transcripts were examined by RT-PCR, quantitative PCR, cloning and sequencing.
RESULTS: Database searching revealed the presence of a retina-specific PRPF31 isoform in mouse. However, this isoform could not be experimentally identified in transcripts from human retina or from a human whole eye. Nevertheless, four different PRPF31 isoforms, that were common to all analyzed tissues and cell lines, were isolated. Three of these harbored the full-length PRPF31 coding sequence, whereas the fourth was very short and probably non-coding. The amount of PRPF31 mRNA was previously found to be lower in patients with mutations in this gene than in healthy individuals, making it likely that retinal cells are more sensitive to variation in PRPF31 expression. However, quantitative PCR experiments revealed that PRPF31 mRNA levels in human retina were comparable to those detected in other tissues.
CONCLUSIONS: Our results show that the retina-restricted phenotype caused by PRPF31 mutations cannot be explained by the presence of tissue-specific isoforms, or by differential expression of PRPF31 in the retina. As a consequence, the etiology of PRPF31-associated retinitis pigmentosa likely relies on other, probably more subtle molecular mechanisms.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19373678     DOI: 10.1080/13816810902744621

Source DB:  PubMed          Journal:  Ophthalmic Genet        ISSN: 1381-6810            Impact factor:   1.803


  5 in total

1.  PRPF mutations are associated with generalized defects in spliceosome formation and pre-mRNA splicing in patients with retinitis pigmentosa.

Authors:  Goranka Tanackovic; Adriana Ransijn; Philippe Thibault; Sherif Abou Elela; Roscoe Klinck; Eliot L Berson; Benoit Chabot; Carlo Rivolta
Journal:  Hum Mol Genet       Date:  2011-03-05       Impact factor: 6.150

2.  Dominant PRPF31 mutations are hypostatic to a recessive CNOT3 polymorphism in retinitis pigmentosa: a novel phenomenon of "linked trans-acting epistasis".

Authors:  Anna M Rose; Amna Z Shah; Giulia Venturini; Carlo Rivolta; Geoffrey E Rose; Shomi S Bhattacharya
Journal:  Ann Hum Genet       Date:  2013-10-14       Impact factor: 1.670

3.  Disrupted alternative splicing for genes implicated in splicing and ciliogenesis causes PRPF31 retinitis pigmentosa.

Authors:  Adriana Buskin; Lili Zhu; Valeria Chichagova; Basudha Basu; Sina Mozaffari-Jovin; David Dolan; Alastair Droop; Joseph Collin; Revital Bronstein; Sudeep Mehrotra; Michael Farkas; Gerrit Hilgen; Kathryn White; Kuan-Ting Pan; Achim Treumann; Dean Hallam; Katarzyna Bialas; Git Chung; Carla Mellough; Yuchun Ding; Natalio Krasnogor; Stefan Przyborski; Simon Zwolinski; Jumana Al-Aama; Sameer Alharthi; Yaobo Xu; Gabrielle Wheway; Katarzyna Szymanska; Martin McKibbin; Chris F Inglehearn; David J Elliott; Susan Lindsay; Robin R Ali; David H Steel; Lyle Armstrong; Evelyne Sernagor; Henning Urlaub; Eric Pierce; Reinhard Lührmann; Sushma-Nagaraja Grellscheid; Colin A Johnson; Majlinda Lako
Journal:  Nat Commun       Date:  2018-10-12       Impact factor: 14.919

4.  A novel PRPF31 mutation in a large Chinese family with autosomal dominant retinitis pigmentosa and macular degeneration.

Authors:  Fang Lu; Lulin Huang; Chuntao Lei; Guiquan Sha; Hong Zheng; Xiaoqi Liu; Jiyun Yang; Yi Shi; Ying Lin; Bo Gong; Xianjun Zhu; Shi Ma; Lifeng Qiao; He Lin; Jing Cheng; Zhenglin Yang
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

5.  Identification of a novel pathogenic missense mutation in PRPF31 using whole exome sequencing: a case report.

Authors:  Laura Bryant; Olga Lozynska; Anson Marsh; Tyler E Papp; Lucas van Gorder; Leona W Serrano; Xiaowu Gai; Albert M Maguire; Tomas S Aleman; Jean Bennett
Journal:  Br J Ophthalmol       Date:  2018-07-20       Impact factor: 4.638

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.